IMA
ImageneBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.72
−5.98%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.83
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.63
- EPS estimate
- -$0.98
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -10.3%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.98 | -$0.63 | Beat 35.50% | — |
| May 7, 2026 | -$0.70 | -$0.95 | Miss -35.71% | — |
| Nov 12, 2025 | -$1.47 | -$2.91 | Miss -97.96% | — |
| Jul 24, 2025 | -$0.14 | -$0.06 | Beat 57.14% | — |
| May 8, 2025 | -$0.21 | -$0.18 | Beat 14.29% | — |
| Mar 6, 2025 | -$0.19 | -$0.18 | Beat 5.26% | — |
| Nov 7, 2024 | -$0.27 | -$0.19 | Beat 29.63% | — |
| Aug 8, 2024 | -$0.31 | -$0.27 | Beat 12.90% | — |
| Mar 12, 2024 | -$0.41 | -$0.41 | In line | $659.0K |
| Nov 9, 2023 | -$0.44 | -$0.40 | Beat 9.09% | $1.2M |
| Aug 10, 2023 | -$0.48 | -$0.44 | Beat 8.33% | $2.0M |
| May 15, 2023 | -$0.46 | -$0.39 | Beat 15.22% | $5.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026